Menu
Novo Nordisk and Merck exempted certain states and reversed exemptions in others, following court rulings, threats of enforcement actions and a new state law.

Novo Nordisk Exempts 10 States from In-House Claims Data Reqs, Merck Exempts Washington from CP Restrictions, Reimplements Them in Three States 

Luke Zarzecki, National Correspondent 340B Report Views
Two major pharmaceutical companies exempted certain states and reversed exemptions in others, following court rulings, threats of enforcement actions and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Minnesota Lawmakers Fail to Advance Bill Strengthening 340B Contract Pharmacy Access Law

340B Stakeholders Cheer the Addition of Sen. Boozman to 340B Working Group

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live